Summary Immunocytochemical staining with monoclonal antibody NCRC 11 of formalin fixed paraffin embedded tumour tissue has been studied in 444 cases of primary breast cancer with a minimum follow period of 6 years. The relationship between extent of staining, assessed on a four point scale, and patient survival has been confirmed. There are significant relationships between staining and both histological grade and oestrogen receptor status. No association has been shown between staining and lymph node stage or tumour size. Simplification of staining assessment by modification to two staining groups still allows significant separation of patients into prognostic groups and incorporation into an existing prognostic index.
NCRC 11 is a mouse monoclonal antibody which was raised against human breast carcinoma cells (Ellis -et al., 1984) . The immunoreactivity of this antibody in normal tissues has been described and is similar to other monoclonal antibodies raised against human milk fat globule membrane (HMFGM) (Ellis et al., 1984) . Using these antibodies some workers have shown a relationship between immunocytochemical staining and patient survival (Wilkinson et al., 1984) but others have failed to show any prognostic significance (Berry et al., 1985; Rasmussen et al., 1985) . A preliminary study using NCRC 11 showed a relationship between immunocytochemical staining of formalin fixed paraffin embedded tumour tissue sections and patient survival (Ellis et al., 1985) . We now report a further large retrospective study of primary breast cancer patients using this antibody.
Materials and methods

Clinical data
Five hundred consecutive patients presenting to one surgeon (RWBI) with primary operable breast cancer were selected for study. The patients presented between 1973 and 1979 and have a minimum follow up period of 6 years. Patients were excluded because of lack of follow up information, if in situ tumour only was present, or if insufficient tumour tissue remained for study. This left 444 cases in the study group.
All the patients were treated by simple mastectomy with node sampling from the low axilla, the apex of the axilla, and the internal mammary chain at the second intercostal space. All were followed up at 3 monthly intervals to 18 months, then every 6 months to 5 years, and once a year thereafter. No prophylactic radiotherapy was given. A small group of women were given adjuvant chemotherapy, but this failed to influence survival (Haybittle et al., 1982) .
Detailed clinical and pathological information was available on all patients, including histological grade and lymph node stage. Histological grade was assessed by a modification of the method of Bloom and Richardson (1957) described by Elston (1984) . In 389 cases oestrogen receptor status was determined by the dextran coated charcoal method (Maynard et al., 1978) . Tumours were considered to be positive for oestrogen receptor if values greater than 5 fmol mg-1 cytosol protein were found. (Sternberger, 1979) . Diaminobenzidine was used as the chromogen and the sections were counterstained with haematoxylin.
NCRC In our preliminary study (Ellis et al., 1985) we used similar commercial antisera which were in routine use in our laboratory. In subsequent unpublished work we noticed a greater degree of staining in a series of breast cancers under study. This observation followed replacement of some of the intermediate step antibodies by the manufacturer for improved antibodies. These, especially the rabbit antimouse, appear to be of higher affinity and have increased the sensitivity of the peroxidase antiperoxidase technique allowing detection of low levels of antigen which were undetectable previously.
Reduction of the NCRC 11 concentration below a titre of 1 in 10 reduced the proportion of cells detected as positive in some cases. The cells which lost detectable staining had a light diffuse cytoplasmic staining pattern when observed as positive. Increase of the NCRC 11 concentration, using a purified antibody preparation, did not increase the proportion of cells detected as positive in the cases studied. Similarly trials of two other sensitive immunocytochemical techniques, the immunogold silver staining method (Holgate et al., 1983) and the avidin biotin complex system (Hsu et al., 1981) , did not increase the proportion of cells staining positively.
In each case a negative control section was stained using a mouse IgM monoclonal antibody against sheep erythrocytes (Sera-Lab). A positive control section of breast carcinoma of known reactivity was included with each batch to ensure consistency.
Scoring of staining
The staining of each tumour was assessed in a semiquantitative manner by two observers (IOE, JB) synchronously using a double headed microscope, without prior knowledge of the clinical or pathological data. Each slide was scanned at low power magnification ( x 63) and selected areas at high power magnification (x 160 and x 400). The number of tumour cells staining positively was assessed and scored on a four point scale based on the proportion of the total number of tumour cells: 1-25% = 1, 26-50% =2, 51-75% =3, 76-100% =4. A cell was counted as positive if stain product was present on all or part of the cell surface membrane or in the cytoplasm. In this study no account was taken of the intensity of stain product nor of the difference in staining patterns (surface or cytoplasmic) of the tumour cells.
To test reproducibility 44 cases were selected using random number tables, restained and scored.
Results
Of the 444 cases studied only one showed no evidence of staining. This was an unusual case of spindle cell carcinoma type. There was a variation of staining observed in the 443 positive cases, from cases with all tumour cells staining positively to cases with less than 10 50-74%, group 3 (c); 25-49%, group 2 (d); to 1-25%, group 1 (e) ( x 220). I I between the grades as follows:
1: 48 (11%), 2: 48 (11%), 3: 109 (25%), 4: 238 (53%). Of the 44 cases restained 34 (78%) were scored identically the remainder were placed in an adjacent staining group.
The relationship between staining and histological grade oestrogen receptor status, lymph node stage and tumour size are shown in Tables I, II , III and IV respectively. (Haybittle et al., 1982) . This index has been applied to the study group using the cut off points of <3.4 and >5.4 identified previously (Haybittle et al., 1982) . Three groups of patients with a good (<3.4), moderate (3.5-5.3) and a poor (>5.4) survival are identified (Figure 4) . Subdivision of each group based on NCRC 11 staining grade ( Figure 5 ) identifies a significant bad prognostic subgroup in the good and poor prognostic groups.
To test whether this relationship of NCRC 11 staining with survival was independent of other prognostic factors a Cox analysis (Cox, 1972) analysis are shown to be of significant value along with histological grade and lymph node stage. Histological grade and oestrogen receptor status show a strong direct relationship (Williams et al., 1984) , and both have an association with NCRC 11 staining. It is probable that production of NCRC 11 antigen is related to tumour cell differentiation and the associations with histological grade and ER would be expected. Both lymph node stage and tumour size are factors related to time and show no relationship to NCRC 11 staining.
Simplification of the scoring technique by combining groups 1 and 2, and groups 3 and 4 also gives significant patient stratification. This should reduce intra and inter observer error and make assessment of staining more applicable to routine use. A prognostic index using histological grade, lymph node stage and tumour size has been shown to be an accurate predictor of patient outcome in breast carcinoma (Haybittle et al., 1982) . The results of this study indicate that addition of NCRC 11 staining grade can improve this prognostic index by identification of bad prognostic subgroups in the good and poor prognostic groups. It may be possible to improve the prognostic index further by incorporation of NCRC 11 staining with, or as a substitute for tumour size.
The distribution between the staining groups is different from the results of our previous published preliminary study (Ellis et al., 1985) The results of other groups using similar antibodies have been conflicting. Wilkinson et al. (1984) , using HMFGI and HMFG2, reported a significant association between extra cellular staining with HMFGI and good survival in patients with breast cancer. Other groups, using HMFGI and HMFG2 (Berry et al., 1985) , and Mam 3 antibodies (Rasmussen et al., 1985) , also raised to HMFGM have not confirmed these results. The glycoprotein antigen Mam 6, present on the HMFGM has been shown to be elevated in the serum of patients with breast carcinoma, particularly those patients with tumours of an advanced stage . The epitope identified by one antibody to this antigen, 11 5D8, although not the epitope identified by NCRC 11, is present on the NCRC 11 antigen (Price et al., 1986) . Work with NCRC 11 is in progress in other laboratories. Preliminary results from one group (Angus et al., 1986) have shown that patients whose tumours had a low number of cells staining positively had a poorer prognosis, but this did not attain statistical significance. However the follow up period in the study was short, with a minimum of 30 months.
The assessment of immunohistological staining with NCRC 11 used in this study is a relatively simple semiquantitative method. It does not account for the many different patterns and variable distribution of the NCRC 11 antigen seen in breast carcinomas, from purely luminal surface staining ( Figure IA) to diffuse intracytoplasmic staining ( Figure IB) . Analysis of these patterns may show relationships to histological tumour type or give information about the relationships to histological grade and may improve the understanding of the diverse morphological patterns of human breast cancer.
